Recent research has focused on understanding the pathology of equine lymphomas, their association with hematological disorders, and the implications for diagnosis and treatment. One notable study ...
These inclusions typically consist of immunoglobulins, and CSH is often associated with various hematological disorders, particularly those involving B-lymphocytes, such as multiple myeloma and ...
Regenecyte is under clinical development by StemCyte and currently in Pre-Registration for Unspecified Hematological Disorders. According to GlobalData, Pre-Registration drugs for Unspecified ...
Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.